Genexe Global Farmacy Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -23.21%
- Profit Growth -82.94%
- Ebitda -344.60%
- Net Worth 10.41%
- Total Assets 38.36%
About Genexe Global Farmacy
Genexe Global Farmacy Private Limited (GGFPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 September 2017 (Seven years and four months 30 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Prithipal Bhullar and Vikas Sahni serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2017PTC300231
- Company No.
300231
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Sep 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
What products or services does Genexe Global Farmacy Private Limited offer?
Genexe Global Farmacy Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Common Disease Medicines, Pharmaceutical Tablets, TB, Tumor & Cancer Drugs, Anti Cancer Injection, Pharmaceutical Capsules, Anti Infective Drugs & Medicines, HIV Drugs, Antifungal Cream, Ointment & Powder.
Who are the key members and board of directors at Genexe Global Farmacy?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prithipal Bhullar  | Director | 28-Sep-2017 | Current |
| Vikas Sahni | Director | 28-Sep-2017 | Current |
Financial Performance of Genexe Global Farmacy.
Genexe Global Farmacy Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 23.21% decrease. The company also saw a substantial fall in profitability, with a 82.94% decrease in profit. The company's net worth Soared by an impressive increase of 10.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genexe Global Farmacy?
In 2020, Genexe Global Farmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genexe Global Farmacy?
Unlock and access historical data on people associated with Genexe Global Farmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genexe Global Farmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genexe Global Farmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.